Open Beta
TREN
MetriLume
TREN

US marketsKYNB

SEC-sourced researchBeta

KYNB

KYNTRA BIO, INC.

Company comparison ↗

Data passport

CIK
0000921299
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 29,621,000.0000 USD; December 2025: 6,440,000.0000 USD29.6M USD0 USD0December 2024December 2025
KYNB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202429,621,000.0000Mar 16, 2026
December 20256,440,000.0000Mar 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20256,440,000.0000183,452,000.0000-4,774,000.0000119,594,000.0000115,119,000.0000Mar 16, 2026
December 202429,621,000.0000-47,579,000.0000-137,999,000.0000214,525,000.0000398,160,000.0000Mar 16, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$6.44MDecember 2025Mar 16, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$29.62MDecember 2024Mar 16, 202610-K
Net incomeNetIncomeLoss$183.45MDecember 2025Mar 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$4.77MDecember 2025Mar 16, 202610-K
Total assetsAssets$119.59MDecember 2025Mar 16, 202610-K
Total liabilitiesLiabilities$115.12MDecember 2025Mar 16, 202610-K

New filings

Explore methodology ↗